Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2020-04-27 Regulatory Filings
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2020-04-27 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a notice regarding the upcoming Annual General Meeting (AGM) of Cresco Labs Inc., specifying the meeting type, date, record dates, and voting details. It does not contain any presentations, materials, or detailed reports from the AGM itself, nor does it include financial data or results. The document is short (1226 characters) and serves as an announcement of meeting logistics rather than the meeting content or results. Therefore, it fits best under AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices about the AGM.
2020-04-27 English
Material change report - English.pdf
Regulatory Filings
2020-03-13 English
News release - English.pdf
Regulatory Filings
2020-03-12 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing the closing of an acquisition and the launch of adult-use cannabis sales in Massachusetts by Cresco Labs. It details the acquisition of Hope Heal Health, Inc., regulatory approval, and operational plans. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is an announcement of a corporate event related to M&A activity rather than a full merger filing or tender offer document. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. The content aligns best with M&A Activity announcements, which cover merger proposals or takeover bids and related corporate transactions.
2020-02-07 English
Material document(s).pdf
Regulatory Filings Classification · 100% confidence The document is a certification form titled 'FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS' signed by the CEO certifying the accuracy and fairness of the interim financial report and interim MD&A for the period ended December 31, 2019. It does not contain the interim financial statements or substantive financial data itself, but rather attests to their correctness and compliance. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3347 characters, which is relatively short and consistent with a certification letter rather than a full interim report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-02-03 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.